Comparing quality of life and urinary outcomes after bladder surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the health-related quality of life (HRQOL) and urinary outcomes in patients who have undergone partial cystectomy compared to those who have had radical cystectomy. Patients will complete questionnaires to provide data on their experiences post-surgery, and their medical records will be reviewed for additional insights. The study aims to identify how various patient-specific characteristics influence these outcomes among the two groups. By comparing these cohorts, the study seeks to enhance understanding of the impacts of different surgical approaches on patient well-being.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Currently living partial cystectomy patients in Mayo Urology's cystectomy registry and patients undergoing radical or partial cystectomy
* Matched 2:1 living radical cystectomy to partial cystectomy patients
* Either urothelial or non-urothelial histology

Exclusion Criteria:

* Partial cystectomy patients that underwent subsequent radical cystectomy

Where it's running

• Mayo Clinic in Rochester
  Rochester, Minnesota, United States Recruiting

Study contacts

• Principal investigator: Vidit Sharma, MD — Mayo Clinic
• Study coordinator: Clinical Trials Referral Office
• Email: mayocliniccancerstudies@mayo.edu
• Phone: 855-776-0015

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• In-home cancer treatment with remote specialist support for patients in the Florida Panhandle

  This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT07285044

• MRI-first treatment pathway for muscle-invasive bladder cancer

  This trial tests whether using a multiparametric bladder MRI to skip a staging TURBt can speed up care for people with biopsy-proven muscle-invasive bladder cancer.

  Recruiting Phase 3 University of Rome Tor Vergata · Rome, RM · NCT07067749

• Vanguard: a new blood test approach to screen for multiple cancers

  This study will test two different blood-based multi-cancer detection tests in adults 45–75 without cancer to see if they find cancers earlier than usual care.

  Recruiting at 46 sites National Cancer Institute (NCI) · Pleasanton, California and 45 other locations · NCT06995898

• Imaging study using two antibody fragments in patients with solid tumors

  This study is testing two special antibody fragments in people with solid tumors to see how well they target cancer cells and how they move through the body.

  Recruiting Early Phase 1 Var2 Pharmaceuticals · Groningen, Provincie Groningen · NCT06645808

• Collecting blood and urine samples from bladder cancer patients

  This study is collecting blood and urine samples from bladder cancer patients to see if these samples can help create better tests for early detection of the disease.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT06109857

• Using light and occupational therapy to manage fatigue in cancer patients

  This study is testing if combining light therapy with occupational therapy can help cancer patients with genitourinary cancers feel less tired and improve their daily activities.

  Recruiting City of Hope Medical Center · Duarte, California · NCT05519878

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.